Stock Taper
MRNA
MODERNA, INC.
NASDAQ
$148.87
▲ UP 6.08% (8.53)

KEY STATISTICS

Market Cap$54.70 B
52w High$176.66
52w Low$22.28
Dividend Yield
Frequency
P/E-18.27
Volume15.74M
Shares Out.396.79M

COMPANY

LEADERSHIP

Stéphane Bancel
CHIEF EXECUTIVE
Stéphane Bancel

COMPENSATION 2026

Salary$1,677,739
Stock Awards$6,897,455
Incentive Plan Pay$4,302,360
All Other Comp.$157,238
Total$19,932,217

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 7, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
4,700

PRICE TARGET

Target High$245.00
Target Low$25.00
Target Median$125.00
Target Consensus$114.82

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$876.66M
NOV
5
THU

PRICE

$148.87 ▲ UP 6.08% (+$8.53)
$140$144$1489:30 AM10:14 AM10:58 AM11:43 AM12:27 PM1:11 PM1:55 PM148.87

About Moderna, Inc.

https://www.modernatx.com ↗

Moderna, Inc. is a biotech company developing mRNA therapeutics and vaccines for infectious, autoimmune, and cancer diseases worldwide, with strategic partnerships and a diverse portfolio including COVID-19, flu, and personalized cancer vaccines.

INDUSTRY

Biotechnology

A PRODUCT MODERNA, INC. IS KNOWN FOR

mNEXSPIKE® (COVID-19 Vaccine, mRNA)
mNEXSPIKE® (COVID-19 Vaccine, mRNA)

Moderna's FDA-approved, lower-dose next-generation COVID-19 vaccine for the 2025-2026 season is its latest key product in the COVID-19 franchise.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product Sales$1.97B $1.05B $352M $171M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$782M $298M $73M $70M
Europe$16M $37M $239M $16M
Rest of the World$175M $347M $40M $8M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2026-01-29
Rob Bresnahan
Rob Bresnahan
Sale (Full)
2025-04-08
Julie Johnson
Julie Johnson
Sale (Full)
2025-01-15
Josh Gottheimer
Josh Gottheimer
Sale (Full)
2024-02-01

INSIDER TRADES

DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Bancel Stephane
Sale · 64.9K shares
2026-08-06
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Bancel Stephane
Sale · 128.4K shares
2026-08-05
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Bancel Stephane
Purchase · 252.5K shares
2026-08-06
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Bancel Stephane
Sale · 124.8K shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 3
EQUAL WEIGHT 2
UNDERPERFORM 2
PEER PERFORM 1
UNDERWEIGHT 1
OUTPERFORM 1
SECTOR PERFORM 1
OVERWEIGHT 1
IN LINE 1
HOLD 1
14 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
RVMD$203.78COMPARE
JAZZ$251.77COMPARE
BBIO$76.02COMPARE
EXEL$54.46COMPARE
BMRN$65.95COMPARE
HALO$106.37COMPARE
MDGL$529.53COMPARE
TECH$72.32COMPARE